(May 30, 2025) – The Centers for Medicare & Medicaid Services requested information about improving prescription drug price transparency, new guidance about hospital price transparency and an updated price transparency resources website. These actions will "strengthen two key regulatory actions," transparency in coverage final regulations and the hospital price transparency final regulations.
CMS also released a request for information about how to identify challenges and improve compliance and enforcement processes related to the transparent reporting of complete, accurate and meaningful pricing data by hospitals. Comments about the prescription drug price transparency request for information will be due 30 days following publication in the Federal Register, and comments about the hospital price transparency request for information will be due by 10:59 p.m. on Monday, July 21.
--Jaron Caffrey